Cor­rect­ed: Ex­perts to de­cide with­in a year whether to rec­om­mend Duchenne mus­cu­lar dy­s­tro­phy for new­born screen­ing

An ad­vi­so­ry com­mit­tee has post­poned its de­ci­sion to de­cide whether Duchenne mus­cu­lar dy­s­tro­phy should be in­clud­ed in a fed­er­al­ly-rec­om­mend­ed new­born screen­ing pan­el for up to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Senior Associate - Life Science

Alexandria Real Estate Equities

Seattle, WA, USA